MarketPeel
Insider Trading Intelligence
JK

John J. Kirby

VRCA
INTERIM CFO · VERRICA PHARMACEUTICALS INC. · CIK 0001556327
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$15.0K
COMPANIES
1
ACTIVE SINCE
Nov 2024
HOLDINGS NOW
18,962
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by John J. Kirby, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+31.45%+0.96%+30.48%+30.48%
14d2+100.00%+61.52%+1.19%+60.34%+60.34%
30d2+100.00%+62.70%+2.27%+60.42%+60.42%
60d2+100.00%+44.92%+2.10%+42.82%+42.82%
90d2+100.00%+9.57%+1.09%+8.48%+8.48%
180d2+100.00%+15.23%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRCA · 18,962 shares · as of Dec 23, 2025
013,56727,13440,70054,2672025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
FLOW · 4 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00018,962Dec 23, 2025Dec 30, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
Interim CFO
884884Nov 25, 2025Nov 25, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
Interim CFO
3,536$4.24$15.0K8,962Nov 25, 2025Nov 25, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
54,26754,267Nov 6, 2024Nov 6, 2024View →
Other insiders · VRCA
Loading peer insiders…
About this filer
CIK 0001556327
ROLE
Interim CFO
PRIMARY
VRCA
COMPANIES
1
ACTIVE SINCE
Nov 2024
MARKETPEEL · /INSIDER/0001556327DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback